These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11469725)

  • 1. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.
    Ngui JS; Chen Q; Shou M; Wang RW; Stearns RA; Baillie TA; Tang W
    Drug Metab Dispos; 2001 Jun; 29(6):877-86. PubMed ID: 11353757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different recombinant systems on the cooperativity exhibited by cytochrome P4503A4.
    Zhang Z; Li Y; Shou M; Zhang Y; Ngui JS; Stearns RA; Evans DC; Baillie TA; Tang W
    Xenobiotica; 2004 May; 34(5):473-86. PubMed ID: 15370963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism.
    Kenworthy KE; Clarke SE; Andrews J; Houston JB
    Drug Metab Dispos; 2001 Dec; 29(12):1644-51. PubMed ID: 11717184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
    Rougée LRA; Bedwell DW; Hansen K; Abraham TL; Hall SD
    Drug Metab Dispos; 2023 Oct; 51(10):1372-1380. PubMed ID: 37524542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
    Hosea NA; Miller GP; Guengerich FP
    Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.
    Kenworthy KE; Bloomer JC; Clarke SE; Houston JB
    Br J Clin Pharmacol; 1999 Nov; 48(5):716-27. PubMed ID: 10594474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine.
    Ngui JS; Tang W; Stearns RA; Shou M; Miller RR; Zhang Y; Lin JH; Baillie TA
    Drug Metab Dispos; 2000 Sep; 28(9):1043-50. PubMed ID: 10950847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of diclofenac--enzymology and toxicology perspectives.
    Tang W
    Curr Drug Metab; 2003 Aug; 4(4):319-29. PubMed ID: 12871048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms.
    Stresser DM; Kupfer D
    Biochem Pharmacol; 1998 Jun; 55(11):1861-71. PubMed ID: 9714305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
    Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics of heterotropic cooperativity between alpha-naphthoflavone and testosterone binding to CYP3A4.
    Roberts AG; Atkins WM
    Arch Biochem Biophys; 2007 Jul; 463(1):89-101. PubMed ID: 17459328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 3A4: regulation and role in drug metabolism.
    Guengerich FP
    Annu Rev Pharmacol Toxicol; 1999; 39():1-17. PubMed ID: 10331074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5'-methylhydroxylation by quinidine and hydroquinidine in vitro.
    Ludwig E; Schmid J; Beschke K; Ebner T
    J Pharmacol Exp Ther; 1999 Jul; 290(1):1-8. PubMed ID: 10381752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics.
    Harlow GR; Halpert JR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6636-41. PubMed ID: 9618464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights into the Heterotropic Allosteric Mechanism in Cytochrome P450 3A4-Mediated Midazolam Metabolism.
    Fu T; Zhang H; Zheng Q
    J Chem Inf Model; 2022 Nov; 62(22):5762-5770. PubMed ID: 36342224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine.
    Masubuchi Y; Ose A; Horie T
    Drug Metab Dispos; 2002 Oct; 30(10):1143-8. PubMed ID: 12228192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.